Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...
Viatris (VTRS) targets 5–6% revenue and 9–10% EPS CAGR through 2030, backed by launches, pipeline and $11B M&A cash. Click ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results